摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(2-硝基苯基磺酰基)哌啶 | 314283-05-1

中文名称
1-(2-硝基苯基磺酰基)哌啶
中文别名
——
英文名称
2-nitrobenzenesulfopiperidide
英文别名
1-(2-nitrophenylsulfonyl)piperidine;1-(2-nitrophenyl)piperidine;1-((2-Nitrophenyl)sulfonyl)piperidine;1-(2-nitrophenyl)sulfonylpiperidine
1-(2-硝基苯基磺酰基)哌啶化学式
CAS
314283-05-1
化学式
C11H14N2O4S
mdl
MFCD00514602
分子量
270.309
InChiKey
AACRWZVDRSTLKY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    95 °C(Solv: ethanol (64-17-5))
  • 沸点:
    436.6±47.0 °C(Predicted)
  • 密度:
    1.374±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.8
  • 重原子数:
    18
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.454
  • 拓扑面积:
    91.6
  • 氢给体数:
    0
  • 氢受体数:
    5

安全信息

  • 海关编码:
    2935009090

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-(2-硝基苯基磺酰基)哌啶 在 palladium 10% on activated carbon 、 氢气 作用下, 以 乙醇 为溶剂, 以86%的产率得到1-[(2-氨基苯基)磺酰基]哌啶
    参考文献:
    名称:
    N-Cycloamino substituent effects on the packing architecture of ortho-sulfanilamide molecular crystals and their in silico carbonic anhydrase II and IX inhibitory activities
    摘要:
    为了寻找具有治疗特性的新型 "磺胺药物",我们合成了邻硝基磺酰胺和 N-环氨基邻磺酰苯胺,并利用 1H NMR、13C NMR 和 FT-IR 光谱以及单晶 X 射线衍射(SC-XRD)等技术对其进行了表征。计算得出的密度泛函理论(DFT)优化的分子几何形状与 SC-XRD 得到的构象相似。N-piperidinyl-o-sulfanilamide 和 N-indolinyl-o-sulfanilamide 的分子对接支持了邻磺酰胺能够与人类碳酸酐酶 II 和 IX 抑制剂(hCA II 和 IX;PDB 条目 4iwz 和 5fl4)结合的观点。对三种邻硝基磺酰胺{1-[(2-硝基苯基)磺酰基]吡咯烷,C10H12N2O4S,1,1-[(2-硝基苯基)磺酰基]哌啶、1-[(2-硝基苯基)磺酰基]吡咯烷,C10H12N2O4S,1;1-[(2-硝基苯基)磺酰基]哌啶,C11H14N2O4S,2;和 1-[(2-硝基苯基)磺酰基]-2,3-二氢-1H-吲哚,C14H12N2O4S,3}以及三种 N-环氨基邻磺酰苯胺[2-(吡咯烷-1-磺酰基)苯胺,C10H14N2O2S,4、2-(哌啶-1-磺酰基)苯胺,C11H16N2O2S,5 和 2-(2,3-二氢-1H-吲哚-1-磺酰基)苯胺,C14H14N2O2S,6]表明,氢键和 π-π 相互作用等力将分子连接在一起,并进一步表明,电荷转移可促进生物活性以及在哌啶基和苯基上形成生物相互作用的能力。
    DOI:
    10.1107/s2053229622010130
  • 作为产物:
    参考文献:
    名称:
    Acylating and arylsulfonylating ability of O-derivatives of isatin 3-oximes
    摘要:
    DOI:
    10.1007/s10593-005-0114-7
点击查看最新优质反应信息

文献信息

  • Metal-free synthesis of sulfonamides via iodine-catalyzed oxidative coupling of sulfonyl hydrazides and amines
    作者:Santosh Kumar Reddy Parumala、Rama Krishna Peddinti
    DOI:10.1016/j.tetlet.2016.02.009
    日期:2016.3
    A novel, rapid, and environmentally-friendly protocol for the synthesis of sulfonamides using iodine as catalyst under solvent-free conditions is described. This method involves the oxidative coupling of sulfonyl hydrazides and amines in the presence of catalytic amount of iodine using TBHP as oxidant. This protocol does not require purification techniques such as column chromatography and recrystalization
    描述了一种在无溶剂条件下使用碘作为催化剂合成磺酰胺的新颖,快速且环境友好的方案。该方法涉及在使用TBHP作为氧化剂的催化量碘存在下,磺酰肼和胺的氧化偶联。该方案不需要纯化技术,例如柱色谱法和重结晶法。
  • <i>N</i>-Cycloamino substituent effects on the packing architecture of <i>ortho</i>-sulfanilamide molecular crystals and their <i>in silico</i> carbonic anhydrase II and IX inhibitory activities
    作者:Sherif O. Kolade、Josephat U. Izunobi、Allen T. Gordon、Eric C. Hosten、Idris A. Olasupo、Adeniyi S. Ogunlaja、Olayinka T. Asekun、Oluwole B. Familoni
    DOI:10.1107/s2053229622010130
    日期:2022.12.1

    In the search for new `sulfa drugs' with therapeutic properties, o-nitrosulfonamides and N-cycloamino-o-sulfanilamides were synthesized and characterized using techniques including 1H NMR, 13C NMR and FT–IR spectroscopy, and single-crystal X-ray diffraction (SC-XRD). The calculated density functional theory (DFT)-optimized geometry of the molecules showed similar conformations to those obtained by SC-XRD. Molecular docking of N-piperidinyl-o-sulfanilamide and N-indolinyl-o-sulfanilamide supports the notion that o-sulfanilamides are able to bind to human carbonic anhydrase II and IX inhibitors (hCA II and IX; PDB entries 4iwz and 5fl4). Hirshfeld surface analyses and DFT studies of three o-nitrosulfonamides 1-[(2-nitrophenyl)sulfonyl]pyrrolidine, C10H12N2O4S, 1, 1-[(2-nitrophenyl)sulfonyl]piperidine, C11H14N2O4S, 2, and 1-[(2-nitrophenyl)sulfonyl]-2,3-dihydro-1H-indole, C14H12N2O4S, 3} and three N-cycloamino-o-sulfanilamides [2-(pyrrolidine-1-sulfonyl)aniline, C10H14N2O2S, 4, 2-(piperidine-1-sulfonyl)aniline, C11H16N2O2S, 5, and 2-(2,3-dihydro-1H-indole-1-sulfonyl)aniline, C14H14N2O2S, 6] suggested that forces such as hydrogen bonding and π–π interactions hold molecules together and further showed that charge transfer could promote bioactivity and the ability to form biological interactions at the piperidinyl and phenyl moieties.

    为了寻找具有治疗特性的新型 "磺胺药物",我们合成了邻硝基磺酰胺和 N-环氨基邻磺酰苯胺,并利用 1H NMR、13C NMR 和 FT-IR 光谱以及单晶 X 射线衍射(SC-XRD)等技术对其进行了表征。计算得出的密度泛函理论(DFT)优化的分子几何形状与 SC-XRD 得到的构象相似。N-piperidinyl-o-sulfanilamide 和 N-indolinyl-o-sulfanilamide 的分子对接支持了邻磺酰胺能够与人类碳酸酐酶 II 和 IX 抑制剂(hCA II 和 IX;PDB 条目 4iwz 和 5fl4)结合的观点。对三种邻硝基磺酰胺1-[(2-硝基苯基)磺酰基]吡咯烷,C10H12N2O4S,1,1-[(2-硝基苯基)磺酰基]哌啶、1-[(2-硝基苯基)磺酰基]吡咯烷,C10H12N2O4S,1;1-[(2-硝基苯基)磺酰基]哌啶,C11H14N2O4S,2;和 1-[(2-硝基苯基)磺酰基]-2,3-二氢-1H-吲哚,C14H12N2O4S,3}以及三种 N-环氨基邻磺酰苯胺[2-(吡咯烷-1-磺酰基)苯胺,C10H14N2O2S,4、2-(哌啶-1-磺酰基)苯胺,C11H16N2O2S,5 和 2-(2,3-二氢-1H-吲哚-1-磺酰基)苯胺,C14H14N2O2S,6]表明,氢键和 π-π 相互作用等力将分子连接在一起,并进一步表明,电荷转移可促进生物活性以及在哌啶基和苯基上形成生物相互作用的能力。
  • Acylating and arylsulfonylating ability of O-derivatives of isatin 3-oximes
    作者:A. P. Stankevicius、P. B. Terentiev、L. N. Janushene、A. B. Savickas
    DOI:10.1007/s10593-005-0114-7
    日期:2005.1
  • Synthesis, crystal structure and <i>in-silico</i> evaluation of arylsulfonamide Schiff bases for potential activity against colon cancer
    作者:Sherif O. Kolade、Oluwafemi S. Aina、Allen T. Gordon、Eric C. Hosten、Idris A. Olasupo、Adeniyi S. Ogunlaja、Olayinka T. Asekun、Oluwole B. Familoni
    DOI:10.1107/s205322962400233x
    日期:2024.4.1

    This report presents a comprehensive investigation into the synthesis and characterization of Schiff base compounds derived from benzenesulfonamide. The synthesis process, involved the reaction between N-cycloamino-2-sulfanilamide and various substituted o-salicylaldehydes, resulted in a set of compounds that were subjected to rigorous characterization using advanced spectral techniques, including 1H NMR, 13C NMR and FT–IR spectroscopy, and single-crystal X-ray diffraction. Furthermore, an in-depth assessment of the synthesized compounds was conducted through Absorption, Distribution, Metabolism, Excretion and Toxicity (ADMET) analysis, in conjunction with docking studies, to elucidate their pharmacokinetic profiles and potential. Impressively, the ADMET analysis showcased encouraging drug-likeness properties of the newly synthesized Schiff bases. These computational findings were substantiated by molecular properties derived from density functional theory (DFT) calculations using the B3LYP/6-31G* method within the Jaguar Module of Schrödinger 2023-2 from Maestro (Schrodinger LLC, New York, USA). The exploration of frontier molecular orbitals (HOMO and LUMO) enabled the computation of global reactivity descriptors (GRDs), encompassing charge separation (E gap) and global softness (S). Notably, within this analysis, one Schiff base, namely, 4-bromo-2-N-[2-(pyrrolidine-1-sulfonyl)phenyl]carboximidoyl}phenol, 20, emerged with the smallest charge separation (ΔE gap = 3.5780 eV), signifying heightened potential for biological properties. Conversely, 4-bromo-2-N-[2-(piperidine-1-sulfonyl)phenyl]carboximidoyl}phenol, 17, exhibited the largest charge separation (ΔE gap = 4.9242 eV), implying a relatively lower propensity for biological activity. Moreover, the synthesized Schiff bases displayed remarkeable inhibition of tankyrase poly(ADP-ribose) polymerase enzymes, integral in colon cancer, surpassing the efficacy of a standard drug used for the same purpose. Additionally, their bioavailability scores aligned closely with established medications such as trifluridine and 5-fluorouracil. The exploration of molecular electrostatic potential through colour mapping delved into the electronic behaviour and reactivity tendencies intrinsic to this diverse range of molecules.

  • Reactions of N- and C-alkenylanilines: X. Synthesis of 2-vinyldihydroindoles from 4-methyl-2-(pent-3-en-2-yl)aniline
    作者:G. G. Mazgarova、A. M. Absalyamova、R. R. Gataullin
    DOI:10.1134/s1070428012090096
    日期:2012.9
    2-(1-Iodoethyl)-3,5-dimethyl-1-(4-methylphenylsulfonyl)-2,3-dihydro-1H-indole reacted with pyridine, piperidine, N-alkylpiperidines, and dimethylformamide to give dehydrohalogenation and halogen substitution products whose ratio depended on the reagent structure. Heating of 2-(1-iodoethyl)-3,5-dimethyl-1-methylsulfonyl-2,3-dihydro-1H-indole with piperidine resulted in the formation of only dehydroiodination products.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐